Usefulness of bromocriptine in the treatment of amisulpride-induced hyperprolactinemia: a case report.
Bliesener
N
N
Yokusoglu
H
H
Quednow
B B
BB
Klingmüller
D
D
Kühn
K U
KU
D000328:Adult; D000077582:Amisulpride; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001971:Bromocriptine / Q000627:therapeutic use*; D004958:Estradiol / Q000097:blood; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006727:Hormone Antagonists / Q000627:therapeutic use*; D006801:Humans; D006966:Hyperprolactinemia / Q000139:chemically induced* / Q000188:drug therapy*; D007986:Luteinizing Hormone / Q000097:blood; D008875:Middle Aged; D011388:Prolactin / Q000097:blood; D011618:Psychotic Disorders / Q000188:drug therapy*; D013469:Sulpiride / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use
D014150:Antipsychotic Agents; D006727:Hormone Antagonists; D001971:Bromocriptine; D004958:Estradiol; D013469:Sulpiride; D000077582:Amisulpride; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone